Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 18, 2026.

Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin

Marina Theodosiou, Moritz Widmaier, Ralph T Böttcher and 8 more

eLife · 2016 · CC BY

doi:10.7554/elife.10130

Abstract

Integrins require an activation step prior to ligand binding and signaling. How talin and kindlin contribute to these events in non-hematopoietic cells is poorly understood. Here we report that fibroblasts lacking either talin or kindlin failed to activate β1 integrins, adhere to fibronectin (FN) or maintain their integrins in a high affinity conformation induced by Mn2+. Despite compromised integrin activation and adhesion, Mn2+ enabled talin- but not kindlin-deficient cells to initiate spreading on FN. This isotropic spreading was induced by the ability of kindlin to directly bind paxillin, which in turn bound focal adhesion kinase (FAK) resulting in FAK activation and the formation of lamellipodia. Our findings show that talin and kindlin cooperatively activate integrins leading to FN binding and adhesion, and that kindlin subsequently assembles an essential signaling node at newly formed adhesion sites in a talin-independent manner.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Integrins are heterodimeric transmembrane receptors that mediate cell adhesion to the extracellular matrix (ECM) and to other cells. The consequence of integrin-mediated adhesion is the assembly of a large molecular network that induces various signaling pathways, resulting in cell migration, proliferation, survival and differentiation. The quality and strength of integrin signaling is controlled by the interaction between integrins and substrate-attached ligands, which is, in turn, regulated by the on- and off-rates of the integrin–ligand binding process. The on-rate of the integrin–ligand binding reaction (also called integrin activation or inside-out signaling) is characterized by switching the unbound form of integrins from an inactive (low affinity) to an active (high affinity) conformation. The affinity switch proceeds from a bent and clasped low affinity conformation to an extended and unclasped high affinity conformation with an open ligand-binding pocket. This change in affinity is believed to be induced through the binding of talin and kindlin to the β integrin cytoplasmic domain and divalent cations to distinct sites close to the ligand-binding pocket.

The stabilisation of integrin–ligand complexes is mediated by integrin clustering and catch bond formation between integrin and bound ligand. The stabilizing effect of clustered integrins is achieved by the ability of dissociated integrin–ligand complexes to rebind before they leave the adhesion site, while catch bonds are receptor–ligand bonds whose lifetime increases with mechanical force. Both mechanisms extend the duration and increase the strength of integrin-mediated adhesion and signaling (also called outside-in signaling), and depend on the association of integrins with the actin cytoskeleton via talin, and probably kindlin.

The talin family consists of two (talin-1 and -2) and the kindlin family of three isoforms (kindlin-1-3), which show tissue-specific expression patterns. The majority of studies that defined integrin affinity regulation by talin and kindlin were performed on αIIbβ3 and β2-class integrins expressed by platelets and leukocytes, respectively. These cells circulate in the blood and hold their integrins in an inactive state until they encounter soluble or membrane-bound agonists. The prevailing view is that agonist-induced signaling pathways activate talin-1 and the hematopoietic cell-specific kindlin-3, which cooperate to induce integrin activation and clustering.

Integrin affinity regulation in non-hematopoietic cells such as fibroblasts and epithelial cells is poorly understood. It is not known how integrin activation is induced on these cells (no integrin-activating agonists have been identified) and it is also controversial whether talin and kindlin are required to shift their integrins into the high affinity state. While there are reports showing that talin and kindlin are required for integrin activation in epithelial cells, it was also shown that in myoblasts and mammary epithelial cells activation of β1 integrins, adhesion and spreading on multiple ECM substrates can proceed in the absence of talin. Likewise, it was reported that focal adhesion kinase (FAK)-deficient fibroblasts develop small, nascent adhesions (NAs) at the edge of membrane protrusions without visible talin and that integrins carrying a mutation in the talin-binding site can still nucleate and stabilize NAs. Also fibroblasts lacking talin-1 and -2 were shown to adhere to fibronectin (FN) and initiate isotropic spreading. Another intriguing study demonstrated that overexpression of kindlin-2 in Chinese hamster ovary (CHO) cells inhibits rather than promotes talin head-induced α5β1 integrin activation. Given the fundamental importance of talin and kindlin for integrin activation in hematopoietic cells, the findings of these studies are unexpected and imply that either integrin affinity regulation is substantially different in fibroblasts and epithelial cells or the experimental approaches used to manipulate protein expression and localization were imperfect.

To directly evaluate the functions of talin and kindlins for FN-binding integrins on fibroblasts, we used a genetic approach and derived fibroblasts from mice lacking either the Tln1 and -2 or the Fermt1 and -2 genes. We show that integrin affinity regulation depends on both talin and kindlin, and that kindlin has the additional function of triggering cell spreading by binding directly to paxillin in a talin-independent manner.

Kindlins and talins control cell morphology, adhesion and integrin expression

To obtain cells lacking the expression of talin-1 and kindlin-2, we intercrossed mice carrying loxP flanked (floxed; fl) Tln1 or Fermt2 alleles (Figure 1A), isolated kidney fibroblasts and immortalized them with the SV40 large T antigen (parental fibroblasts). The floxed alleles were deleted by adenoviral Cre recombinase transduction resulting in T1Ko and K2Ko fibroblasts. Loss of talin-1 or kindlin-2 expression in fibroblasts was compensated by talin-2 or the de novo expression of kindlin-1, respectively, allowing adhesion and spreading, although to a lesser extent compared with control cells (Figure 1—figure supplement 1A,B). To prevent this compensation, we generated mice with floxed Tln1 and nullizygous Tln2 alleles or with floxed Fermt1 and -2 alleles (TlnCtr; KindCtr) from which we isolated, immortalized and cloned kidney fibroblasts with comparable integrin surface levels (Figure 1A and Figure 1—figure supplement 2). The floxed alleles were deleted by transducing Cre resulting in talin-1, -2 (TlnKo) and kindlin-1, -2 (KindKo) deficient cells, respectively (Figure 1A–C). Since the TlnCtr and KindCtr control cells showed similar morphologies and behaviour in our experiments, we display one control cell line in several result panels. Cre-mediated deletion of the floxed Tln1 or floxed Fermt1/2 genes was efficient (Figure 1B) and resulted in cell rounding, weak adhesion of a few cells, and reduced cell proliferation despite the immortalisation with the oncogenic large T antigen (Figure 1C and Figure 1—figure supplement 3). To minimize cell passage-induced abnormalities, we used cells only up to 12 passages after Cre-mediated gene deletions.

To define the adhesion defect, we performed plate and wash assays for 30 min on defined substrates and found that neither TlnKo nor KindKo cells adhered to FN, laminin-111 (LN), type I collagen (COL) and vitronectin (VN) (Figure 1D). To test whether the inability of TlnKo and KindKo cells to adhere to ECM proteins is due to an integrin activation defect, we bypassed inside-out activation by treating cells with Mn2+, which binds to the integrin ectodomain and induces unbending and unclasping of integrin heterodimers. Treatment with Mn2+ induced partial adhesion of TlnKo and KindKo cells to FN, while partial adhesion to LN and VN was only induced in TlnKo cells (Figure 1D). Time course experiments revealed that Mn2+-induced adhesion of TlnKo and KindKo cells to FN was already significantly lower 2.5 min after plating and remained significantly lower compared with control cells (Figure 1E), suggesting that talin and kindlin cooperate to initiate and maintain normal Mn2+-induced adhesion to FN. In line with these findings, dose-response profiles showed that TlnKo and KindKo cells have severe adhesion defects at low (1.25 µg ml–1) as well as high (20 µg ml–1) substrate concentrations (Figure 1—figure supplement 4).

These findings indicate that talin and kindlin promote integrin-mediated adhesion to FN and proliferation, and that the integrin-activating compound Mn2+ can only partially substitute for the adhesion promoting roles that talin and kindlin accomplish together.

Integrin activation and binding to FN requires talin and kindlin-2

The inability of Mn2+ to fully rescue the adhesion defect of TlnKo and KindKo cells raised the question whether integrin surface levels change after deletion of the Tln1/2 and Fermt1/2 genes. We quantified integrin surface levels by flow cytometry and found that the levels of β1 and β3 were significantly reduced in KindKo and unaffected in TlnKo cells (Figure 2A and Figure 2—figure supplement 1). The levels of α2 and α3 integrin were reduced in both cell lines, α6 was elevated in TlnKo and decreased in KindKo cells, and the α3 levels were significantly more decreased in KindKo than in TlnKo cells (Figure 2A) explaining the absent adhesion of both cell lines to COL and their differential adhesion behaviour on LN (Figure 1D). The β5 levels were similarly up-regulated in KindKo and TlnKo cells, and the α5 and αv integrin levels were slightly reduced but not significantly different between TlnKo and KindKo cells (Figure 2A). The differential adhesion of Mn2+-treated TlnKo and KindKo cells to VN (Figure 1D), despite similar surface levels of αv integrins, points to particularly important role(s) for kindlin-2 in αv integrins-VN adhesion and signaling. Serendipitously, the reduced expression of β1-associating α2, α3 and α6 subunits in KindKo cells, which impairs adhesion to LN and COL enables α5 to associate with the remaining β1 subunits and leads to comparable α5β1 levels on TlnKo and KindKo cells (Figure 2—figure supplement 2) explaining their similar adhesion to FN (Figure 1D,E and Figure 1—figure supplement 4). Therefore, we performed all further experiments with FN.

Since we excluded different surface levels of FN-binding integrins as a cause for the severely compromised adhesion of TlnKo and KindKo cells to FN, we tested whether talin and kindlin are required to activate FN-binding α5β1 integrins. To directly assess integrin activation, we made use of an antibody against the 9EG7 epitope, which specifically recognizes Mn2+ and/or ligand activated β1 integrins. The amount of 9EG7 epitope exposure relative to total β1 integrin exposure corresponds to the integrin activation index, which can be measured by flow cytometry using 9EG7 and anti-total β1 integrin antibodies. These measurements revealed that TlnCtr and KindCtr cells bound 9EG7 antibodies, while TlnKo and KindKo cells lacked 9EG7 binding in the absence of Mn2+ (Figure 2—figure supplement 3A). Mn2+ treatment significantly increased 9EG7 binding by TlnCtr and KindCtr cells, which was further elevated in the presence of FN-Arg-Gly-Asp (RGD) ligand known to stabilize the high affinity state of integrins (Figure 2—figure supplement 3A). Mn2+-treated TlnKo and KindKo cells bound significantly less 9EG7 antibodies than control cells, which marginally increased with FN-RGD (Figure 2—figure supplement 3A). Moreover, the normalization of the 9EG7 binding to the total β1 integrin surface levels also indicated a significantly lower influence of Mn2+ and FN-RGD on the integrin activation index of KindKo as compared to TlnKo cells (Figure 2—figure supplement 3A). These findings confirm that both, talin and kindlin are required for β1 integrin activation and to stabilize Mn2+-induced unbending/unclasping of α5β1 integrins.

Our findings so far suggest that talin and kindlin are required to activate FN-binding integrins and maintain Mn2+-induced activation of FN-binding integrins. To further analyze whether ligand-induced stabilisation of high-affinity integrin conformations (also termed ‘ligand-induced integrin activation; ) can form in the absence of talin or kindlin, we used atomic force microscopy (AFM)-based single cell force spectroscopy (SCFS). We attached control, TlnKo or KindKo cells to Concanavalin A (ConA)-coated cantilevers, allowed the cells to contact surfaces coated with either wild type FN-III7-10 (FN-RGD) or an integrin-binding-deficient FN-III7-10 fragment lacking the RGD binding motif (FN-ΔRGD) for increasing contact times, either in the absence or presence of Mn2+ and then detached them from the substrate by lifting the cantilever (Figure 2B,C). In the absence of Mn2+ TlnCtr and KindCtr cells developed significant adhesion to FN-RGD within 5 s contact time. After a contact time of 20 s around 2 nN force was required to disrupt adhesion to FN-RGD, and after 50 and 120 s, respectively, 3 and 6 nN were required (Figure 2B). TlnKo and KindKo cells failed to develop measurable adhesions to FN-RGD after contact times of 5, 20, 50 and 120 s (Figure 2B). Treatment with Mn2+ induced a slight and similar increase of force required to disrupt adhesion of control, TlnKo and KindKo cells to FN-RGD after 5 s contact time (Figure 2C). However, with increasing contact times, the AFM profiles of TlnKo and KindKo cells differ in the presence of Mn2+. While the adhesion force increased concomitantly with longer contact times in TlnCtr, KindCtr and TlnKo cells, adhesion forces of KindKo cells plateaued after 50 s and showed no further increase towards 120 s contact time. The latter finding suggests that kindlin stabilizes integrin–ligand complexes with time, by inducing integrin clustering and/or by modulating the off-rate of integrin ligand bonds, for example, through associating with the integrin-linked kinase (ILK)-Pinch-Parvin (IPP) complex that links kindlin to the F-actin cytoskeleton.

We next tested whether their impaired integrin function affects the assembly of FN into fibrils, which requires association of active α5β1 integrin with the actin cytoskeleton, and whether re-expression of talin and kindlin reverts the defects of TlnKo and KindKo cells. While neither TlnKo nor KindKo cells were able to assemble FN fibrils, re-expression of full-length Venus-tagged talin-1 (Tln1V) in TlnKo or GFP-tagged kindlin-2 (K2GFP) in KindKo cells (Figure 2—figure supplement 4) rescued FN fibril assembly and adhesion to FN (Figure 2D,E). Furthermore, neither overexpression of the talin-1 head (THD) nor K2GFP in TlnKo cells, nor Tln1V or THD in KindKo cells rescued adhesion to FN or 9EG7 binding (Figure 2E and Figure 2—figure supplement 3B).

Altogether, our results demonstrate that both talin and kindlin are required (1) for ligand-induced stabilisation of integrin-ligand complexes, (2) to stabilize Mn2+-activated α5β1 integrins, and (3) to induce integrin-mediated FN fibril formation.

TlnKo cells initiate spreading and assemble β1 integrins at protruding membranes

It has been reported that a significant number of talin-2 small interfering RNA (siRNA)-expressing talin-1–/– fibroblasts adhere to FN and initiate isotropic cells spreading. To test whether spreading can also be induced in adherent TlnKo and KindKo cells, we bypassed their adhesion defect with Mn2+, seeded them for 30 min on FN and stained with an antibody against total β1 integrin and the β1 integrin activation epitope-reporting 9EG7 antibody. As expected, TlnCtr or KindCtr cells clustered 9EG7-positive β1 integrins in NAs and focal adhesions (FAs), whose frequency and size increased upon Mn2+ treatment (Figure 3A,B). In contrast, the sporadic and very weakly adherent TlnKo and KindKo cells were small, round and formed small and finely dispersed β1 integrin aggregates over the entire cell (Figure 3A) and lacked 9EG7-positive signals (Figure 3B) in the absence of Mn2+ treatment. Upon Mn2+ treatment 37 ± 1% (n=684, mean ± standard deviation of three independent experiments) of the TlnKo cells showed isotropic membrane protrusions (circumferential lamellipodia) with small, dot-like aggregates of β1 integrin, kindlin-2, paxillin and ILK at the membrane periphery (Figure 3A and Figure 3—figure supplement 1), which eventually detached from the substrate leading to the collapse of the protruded membrane (Video 1). Furthermore, 9EG7-positive β1 integrins accumulated along the lamellipodial edge and beneath the nucleus of TlnKo cells (Figure 3B). The remaining cells were spheroid, with half of them showing short, finger-like protrusions, which were motile due to their poor anchorage to the substrate. In the case of KindKo cells, we analysed 652 cells in three independent experiments and found that only 7 ± 1% (mean ± standard deviation) of the cells established lamellipodia, which formed around the entire circumference in 2 ± 0.4% (mean ± standard deviation) of the cells. Around 93 ± 1% of the KindKo cells were spheroid (mean ± standard deviation) and frequently had finger-like, motile protrusions with small dot-like signals containing β1 integrin and talin but rarely paxillin or ILK (Figure 3A and Figure 3—figure supplement 1). Importantly, re-expression of Tln1V in TlnKo cells or K2GFP in KindKo cells normalized FA formation and spreading on FN (Figure 3—figure supplement 2). These findings indicate that kindlin-2 expressing TlnKo cells can initiate the formation of large lamellipodia and assemble β1 integrins in lamellipodial edges.

To further characterize the distribution of β1 integrins in the lamellipodial edges of TlnKo cells, we visualized them by combining direct stochastic optical reconstruction microscopy (dSTORM) and total internal reflection fluorescence microscopy (TIRFM). Mn2+-treated and non-permeablized cells were seeded on FN, stained with anti-total β1 integrin antibodies, and then permeabilized, immunostained for paxillin and imaged with normal resolution TIRFM and dSTORM (Figure 3C). Each localization detected by dSTORM was plotted as a Gaussian distribution around its centre with an average spatial accuracy of ~20 nm (resolution limit of dSTORM imaging). Since two or more localizations from single or multiple dyes in close proximity cannot be distinguished, the number of localizations does not directly reflect integrin numbers. However, all antibody molecules display the same average behaviour with respect to the number of localizations per second in all areas of the cell. This allowed to average the number of localizations per second and µm2 and to plot them in a heat map representation (Figure 3D), which directly reflects the density of stained β1 integrin molecules and thus the degree of integrin clustering. The β1 integrin staining of TlnCtr and KindCtr cells revealed small round structures of ~50 nm diameter indicating clusters of integrins larger than the resolution limit (Figure 3C; high magnification; see arrowheads). Furthermore, high numbers of localizations were enriched in paxillin-positive FAs and in NAs at the lamellipodial edge (Figure 3C; see arrowheads). In these areas, we observed a high average density of 60–120 localizations s–1 µm–2, while outside of the adhesion sites ~0–20 localizations s–1 µm–2 were detected, indicating a high degree of β1 integrin clustering within and a low degree of clustering outside of adhesion sites (Figure 3D). TlnKo cells with circumferential lamellipodia showed a high density of blinking with up to 100 localizations s–1 µm–2 at lamellipodial edges (Figure 3C,D; see arrowheads), which appeared less compact than in control cells. KindKo cells showed >120 localizations s–1 µm–2 in the periphery and finger-like membrane protrusions (Figure 3C,D; see arrowheads), which were also observed in TlnKo cells that adopted a spheroid rather than an isotropic spread shape (Figure 3—figure supplement 3). The exclusive presence of these large and entangled β1 integrin aggregates on TlnKo and KindKo cells with small, spheroid shapes and protrusions suggests that they were induced by spatial constraints rather than specific signaling.

These findings demonstrate that, in contrast to KindKo cells, Mn2+-treated kindlin-2-expressing TlnKo cells induce circumferential membrane protrusions with β1 integrins at the protrusive edges.

Kindlin-2 binds and recruits paxillin to NAs

Our data so far indicate that the expression of kindlin-2 enables initial, isotropic spreading and the accumulation of integrins in lamellipodia of Mn2+-treated TlnKo cells. To identify binding partner(s) of kindlin-2 that transduce this function to downstream effectors, we performed yeast-two-hybrid assays with kindlin-2 as bait using a human complementary DNA (cDNA) library containing all possible open reading frames and a human keratinocyte-derived cDNA library. Among the 124 cDNAs identified from both screenings, 17 coded for leupaxin and 11 for Hic-5. Immunoprecipitation of overexpressed green fluorescent protein (GFP)-tagged paxillin family members, paxillin, Hic-5 and leupaxin in HEK-293 cells with an anti-GFP antibody efficiently co-precipitated FLAG-tagged kindlin-2 (K2flag) (Figure 4A). Conversely, overexpressed GFP-tagged kindlin family members (kindlin-1, kindlin-2, kindlin-3) co-precipitated Cherry-paxillin (Figure 4—figure supplement 1). Since fibroblasts express high levels of paxillin (Figure 4—figure supplement 2), we performed all further interaction analysis with paxillin. Immunoprecipitations of GFP-tagged paxillin or kindlin-2 truncation mutants (Figure 4—figure supplement 3A) revealed that the interaction between kindlin-2 and paxillin was dramatically reduced in the absence of the Lin-11, Isl-1 and Mec-3 (LIM)1-4, LIM2-4 or LIM3-4 domains of paxillin (Figure 4B), or the pleckstrin homology (PH) domain (K2ΔPHGFP; lacking amino acids 380-477) or the N-terminus of kindlin-2 including the F0, F1, and the N-terminal part of the F2 domains (K2NTGFP; terminating at the end of F1; spanning amino acids 1-229) (Figure 4C). As expected, the interaction between kindlin-2 and ILK, which is mediated via a recently identified sequence in the linker domain between the end of the N-terminal F2 and the beginning of the PH domain (amino acids 353–357), was abolished by the K2NTGFP truncation but unaffected by the deletion of the PH domain (K2ΔPHGFP) or the deletion of the N-terminal F0 and F1 domains (K2CTGFP, spanning amino acids 244-680) (Figure 4C). Importantly, immunoprecipitation of KindCtr lysates with antibodies against paxillin co-precipitated kindlin-2 (Figure 4D), confirming interactions between the endogenous proteins. Pull down experiments with recombinant full-length paxillin or paxillin-LIM3 domain and recombinant kindlin-2 demonstrated that binding to LIM3 and full-length paxillin is direct, Zn2+-dependent and abrogated with ethylenediaminetetraacetic acid (EDTA) (Figure 4E and Figure 4—figure supplement 3B). KindKo cells were transduced with K2GFP or K2ΔPHGFP expression constructs, seeded on FN for different times and stained for β1 integrin, paxillin and F-actin. The experiments revealed that the expression of K2GFP in KindKo cells rescued spreading and induced robust paxillin recruitment to β1 integrin-positive NAs (Figure 4F,G). In contrast, expression of K2ΔPHGFP failed to recruit paxillin to β1 integrin-positive adhesion sites at the rim of membrane protrusions (Figure 4F,G) and induce normal cell spreading (Figure 4—figure supplement 4A) despite proper, although weaker, localisation to β1 integrin-positive adhesion sites (Figure 4—figure supplement 4B,C). Interestingly, mature FAs in K2ΔPHGFP-expressing cells were prominent after 30 min and contained significant amounts of paxillin, indicating that paxillin is recruited to mature FAs in a kindlin-2-independent manner (Figure 4F).

These findings indicate that the PH domain of kindlin-2 directly binds the LIM3 domain of paxillin and recruits paxillin into NAs but not into mature FAs.

The kindlin-2/paxillin complex promotes FAK-mediated cell spreading

Our findings revealed that kindlin-2 is required to recruit paxillin to NAs. Paxillin in turn, was shown to bind, cluster and activate FAK in NAs, which leads to the recruitment of p130Cas, Crk and Dock followed by the activation of Rac1 and the induction of cell spreading, and, in concert with growth factor signals, to the activation of Akt-1 followed by the induction of cell proliferation and survival. We therefore hypothesized that the recruitment of paxillin and FAK by kindlin-2 triggers the isotropic spreading and expansion of TlnKo cells. To test this hypothesis, we seeded our cell lines on FN or poly-L-lysine (PLL) in the presence or absence of epidermal growth factor (EGF) and Mn2+. We found that EGF induced similar phosphorylation of tyrosine-992 (Y992) of the epidermal growth factor receptor (pY992-EGFR) in control, TlnKo and KindKo cells. The phosphorylation of tyrosine-397 of FAK (pY379-FAK) in KindCtr cells was strongly induced after the adhesion of control cells on FN and was not further elevated after the addition of EGF and Mn2+ (Figure 5A and Figure 5—figure supplement 1). TlnKo cells also increased pY397-FAK as well as pY31-Pxn and pY118-Pxn levels upon adhesion to FN, however, significantly less compared to control cells (Figure 5A and Figure 5—figure supplement 1A-C). Furthermore, EGF and Mn2+ treatments further increased pY397-FAK levels in TlnKo cells and localized pY397-FAK to peripheral NA-like adhesions (Figure 5A,B and Figure 5—figure supplement 1A-C). In sharp contrast, KindKo cells seeded on FN or treated with EGF and Mn2+ failed to induce pY397-FAK, pY31-Pxn, pY118-Pxn (Figure 5A and Figure 5—figure supplement 1A-C) and localize pY397-FAK to peripheral membrane regions (Figure 5B). Importantly, re-expression of Talin1-Venus in TlnKo and Kindlin2-GFP and KindKo cells fully rescued these signaling defects (Figure 5—figure supplement 1B,C). Furthermore, stable expression of K2GFP in KindKo cells rescued pY397-FAK and pS473-Akt levels (Figure 5C) and co-precipitated paxillin and FAK with K2GFP (Figure 5—figure supplement 2). In contrast, stable expression of K2ΔPHGFP in KindKo cells failed to co-precipitate paxillin and FAK (Figure 5—figure supplement 2) and induce pY397-FAK and pS473-Akt (Figure 5C).

In line with previous reports showing that the paxillin/FAK complex can trigger the activation of p130Cas and, in cooperation with EGFR signaling, the activation of Akt, we observed Y410-p130Cas, pT308-Akt, S473-Akt and pT202/pY204 Erk1/2 phosphorylation after Mn2+ and/or EGF treatment of FN-seeded control and rescued cells, and to a slightly lesser extent TlnKo cells (Figure 5D, Figure 5— figure supplement 3A,B). In contrast, FN-seeded KindKo cells failed to activate p130Cas and showed reduced Akt and Erk1/2 phosphorylation in response to EGF (Figure 5D, Figure 5—figure supplement 3A,B).

Finally, we tested whether the impaired activity of FAK contributed to the spreading defect of KindKo cells by chemically inhibiting FAK activity in TlnKo cells or by overexpressing FAK in KindKo cells (Figure 5E–G). The experiments revealed that inhibiting FAK reduced lamellipodia formation of TlnKo cells to an extent that was similar to untreated KindKo cells (Figure 5E). Conversely, overexpression of FAKGFP in KindKo cells resulted in high active FAK, increased lamellipodial formation and increased cell spreading in TlnKo and KindKo cells (Figure 5F,G and Figure 5—figure supplement 4A,B).

Altogether, these findings show that the kindlin-2/paxillin complex in NAs recruits and activates FAK to induce cell spreading and increase the strength of Akt signaling.

Discussion

While the functions of talin and kindlin for integrin activation, adhesion and integrin-dependent signaling in hematopoietic cells are firmly established, their roles for these processes in non-hematopoietic cells are less clear. To clarify this issue, we established mouse fibroblast cell lines that lacked either talin-1/2 (TlnKo) or kindlin-1/2 (KindKo) and tested whether they were able to activate integrins and mediate substrate adhesion and signaling. In line with previous reports, the deletion of Tln1/2 or Fermt1/2 genes changed the surface levels of laminin- and collagen-binding integrins. Since surface levels of α5 and αv integrins remained unchanged between TlnKo and KindKo cells, we were able to establish the specific roles of talin and kindlin for the function of FN-binding integrins under identical conditions.

A major finding of our study demonstrates that integrin affinity regulation (activation) is essential for fibroblast adhesion and depends on both talin and kindlin-2 (Figure 6A,D). The unambiguity of this finding was unexpected in light of several reports showing that integrin activation and integrin-mediated adhesion still occurs in talin-depleted cells, or is inhibited when kindlin-2 is overexpressed. The previous studies that addressed the functional properties of talin used siRNA-mediated protein depletion, a combination of gene ablation and siRNA technology, or approaches to interfere with talin recruitment to NAs either by ablating the talin upstream protein FAK or by expressing an integrin that harbors a mutation in the talin binding site. Since the majority of approaches deplete rather than eliminate proteins from cells and adhesion sites, the respective cells were most likely recruiting sufficient residual protein to adhesion sites to allow integrin activation, cell adhesion and spreading, and the assembly of adhesion- and signaling-competent NAs. It is possible that not all integrin molecules have to be occupied by talin and therefore low levels of talin suffice, particularly in NAs that were shown by fluorescence correlation spectroscopy to contain only half the number of talin relative to α5β1 integrin and kindlin-2 molecules. However, when the entire pool of talin is lost or decreased below certain thresholds integrins remain inactivate and consequently adhesion sites do not form. With respect to kindlin, it was reported that overexpressed kindlin-2 in CHO cells inhibits rather than promotes talin head domain-induced α5β1 integrin activation. An integrin inhibiting effect of kindlin-2 is inconsistent with our study, which identified a crucial role for kindlin in integrin activation, as well as with other studies also demonstrating that kindlin-2 promotes integrin functions. It could well be that the reported inhibition of α5β1 by kindlin-2 represents an artifact that arose from protein overexpression.

Integrin activation can be induced with Mn2+, whose binding to the ectodomain of β subunits directly shifts integrins into the high affinity state without the requirement for inside-out signals. We observed that Mn2+-treated TlnKo and KindKo cells expressed the activation-dependent epitope 9EG7 and adhered to FN, albeit at significantly lower levels and efficiencies than the normal parental or rescued cells (Figure 6B,C). This observation strongly indicates that talin and kindlin also cooperate to maintain the extended and unclasped conformation of active integrins. Although it is not known how talin and kindlin keep integrins in an active state, it is possible that they stabilize this conformation by linking the unclasped β integrin cytoplasmic domain to the plasma membrane and/or to cortical actin, which may firmly hold separated integrin α/β subunits apart from each other. The expression of mutant talins and kindlins in our cells should allow us to examine these possibilities in future.

Finally, our study also revealed that Mn2+-treated TlnKo cells began to form large, circumferential lamellipodia that eventually detached from FN, leading to the collapse of the protruded membrane. This initial isotropic spreading was significantly less frequent in KindKo cells, and has also been observed in talin-2-depleted talin-1–/– cells on FN, although these cells did not require Mn2+ for inducing spreading, which is likely due to the presence of residual talin-2 that escaped siRNA-mediated depletion. These findings strongly suggest that integrin binding to FN enables kindlin-2 in TlnKo cells to cluster β1 integrins (as shown for αIIbβ3 by kindlin-3 in ) and to trigger a signaling process that initiates spreading.

To find a mechanistic explanation for the kindlin-2-mediated cell spreading, we used the yeast-two-hybrid technology to identify paxillin as a novel and direct binding partner of kindlin-2. The interaction of the two proteins occurs through the LIM3 domain of paxillin, which was previously identified as integrin adhesion-targeting site, and the PH domain of kindlin-2. It is not unusual that PH domains fulfill dual roles by binding phospholipids and proteins, either simultaneously or consecutively. The expression of a PH domain-deficient kindlin-2 in KindKo cells rescues adhesion to FN and FA maturation, however, significantly impairs spreading and plasma membrane protrusions. This finding together with the observations that paxillin-null fibroblasts and embryonic stem cells have defects in spreading, adhesion site remodeling and formation of lamellipodia indicates that the kindlin-2/paxillin complex induces the elusive signaling process, leading to initial spreading of TlnKo and talin-depleted cells. Indeed, the kindlin-2/paxillin complex in NAs recruits FAK, which cooperates with growth factor receptors (such as EGFR) to induce signaling pathways that activate Erk and Akt to promote proliferation and survival, as well as Arp2/3 and Rac1 to induce actin polymerization and membrane protrusions (Figure 6B,E). Kindlin-2 also recruits ILK, which binds in the vicinity of the kindlin-2 PH domain and links integrins to actin and additional signaling pathways (Figure 6E). The short-lived nature of the initial spreading of TlnKo and talin-depleted cells shows that talin concludes the integrin-mediated adhesion process in NAs (Figure 6F) and induces the maturation of FAs. The formation of paxillin-positive FAs in cells expressing the PH domain-deficient kindlin-2 suggests that the recruitment of paxillin to FAs occurs either in a kindlin-independent manner or through a modification of kindlin in a second binding motif.

Mouse strains and cell lines and cell culture

The floxed kindlin-1 (Fermt1flox/flox), floxed talin-1 (Tln1flox/flox) and the constitutive talin-2-null (Tln2–/–) mouse strains have been described. The floxed kindlin-2 (Fermt2flox/flox) mouse strain generated via recombinant recombination in embryonic stem cells carries loxP sites flanking exon 15, which contains the stop codon and the polyadenylation signal of the murine Fermt2 gene. Homologous recombination and germ line transmission were verified by Southern blots, and the frt-flanked neo cassette was removed with a transgenic mouse strain carrying a deleter-flipase gene. Floxed talin-1 and talin-2-null mice, and floxed kindlin-1 and kindlin-2 mice were intercrossed to generate Tln1flox/flox Tln2–/– and Fermt1flox/flox Fermt2flox/flox mice.

The cell lines used in this study are mouse fibroblasts derived from the kidneys of 21 d old mice, immortalized by retrovirally transducing the SV40 large T antigen, cloned (TlnCtr and KindCtr) and finally infected with an adenovirus to transduce the Cre recombinase resulting in talin-null (TlnKo) and kindlin-null (KindKo) cells. The parental cell lines were authenticated based on morphological criteria and the surface experession of specific integrins. All cells were cultured under standard cell culture conditions using Dulbecco's modified Eagle's medium (DMEM) supplemented with 8% fetal calf serum (FCS) and Penicillin/Streptomycin but not subjected to mycoplasma contamination testing.

Flow cytometry

Flow cytometry was carried out with a FACSCantoTMII cytometer (BD Biosciences, Franklin Lakes, NJ, USA) equipped with FACS DiVa software (BD Biosciences) using standard procedures. Data analysis was carried out with the FlowJo program (version 9.4.10). Fibroblasts were incubated with primary antibodies diluted in FACS-Tris buffered saline (FACS-TBS; 30 mM Tris, pH 7.4, 180 mM NaCl, 3.5 mM KCl, supplemented with 1 mM CaCl2, 1 mM MgCl2, 3% BSA, 0,02% NaN3) for 1 hr on ice, washed twice with cold FACS-TBS and finally incubated with the secondary antibody for 45 min on ice.

Real-time polymerase chain reaction

Total RNA was extracted with the RNeasy Mini extraction kit (Qiagen, Germany) from cultured cells, cDNAs were prepared with an iScript cDNA Synthesis Kit (BioRad, Germany) and real-time polymerase chain reaction (PCR) was performed with an iCycler (BioRad). Each sample was measured in triplicate and values were normalized to Gapdh. Primer sequences for Lpxn and Pxn were from PrimerBank (Lpxn: 26080416a1; aPxn: 114326500c2; bPxn: 22902122a1), GAPDH primers were described before and Hic5 primers were newly designed (Hic5-fwd: 5’-ttcctttgcagcggttgttcc-3’; Hic5-rev: 5’-ggttacagaagccacatcgtggg-3’).

Antibodies and inhibitors

The following antibodies or molecular probes were used at indicated concentrations for western blot (WB), immunofluorescence (IF) or flow cytometry (FACS): kindlin-1 (home made), WB: 1:5000, IF: 1:1000; kindlin-2 (MAB2617 from Millipore, Germany) WB: 1:1000, IF: 1:500; talin (8D4 from Sigma, Germany) WB: 1:1000; talin (sc-7534 from Santa Cruz, Germany) IF: 1:500; talin-1 (ab57758 from Abcam, UK) WB: 1:2000; talin-2 (ab105458 from Abcam) WB: 1:2000; GAPDH (6C5 from Calbiochem, Billerica, MA, USA) WB: 1:10,000; Paxillin (610051 from BD Transduction Laboratories, Franklin Lakes, NJ, USA) WB: 1:1000, IF: 1:400; integrin β1-488 (102211 from Biolegend, San Diego, CA, USA) IF: 1:400, FACS: 1:200; integrin β1 (MAB1997 from Chemicon, Billerica, MA, USA) FACS: 1:400; integrin β1-647 (102213 from Biolegend) IF: 1:200; integrin β1 (home-made), IF: 1:400; integrin β3-biotin (553345 from PharMingen, Franklin Lakes, NJ, USA) FACS: 1:200; integrin β3 (M031-0 from Emfret, Germany) IF: 1:200; integrin α2-FITC (554999 from BD Biosciences) FACS: 1:100; integrin α3 (AF2787 from R&D, Germany) FACS: 1:200; integrin α5-biotin (557446 from Pharmingen) FACS: 1:200, IP 1µg; integrin α5 (4705 from Cell Signaling, Germany) WB: 1:1000; integrin α6-FITC (555735 from Pharmingen) FACS 1:100; integrin αv-biotin (551380 from Pharmingen) FACS: 1:200; β1-integrin 9EG7 (550531 from BD Biosciences, San Diego, CA, USA) IF: 1:200; FACS: 1:200; fibronectin (AB2033 from Millipore) IF: 1:500; IgG2a rat isotype control (13-4321 from eBioscience, Germany) FACS: 1:200; IP 1µg; Tritc-Phalloidin (P1951 from Sigma) IF: 1:400; Flag-tag-HRP (8592 from Sigma) WB: 1:10,000; GFP (A11122 from Invitrogen, Germany) WB: 1:2000; Cherry (PM005 from MBL, Woburn, MA, USA) WB:1:1000; Myc (05-724 from Millipore) WB 1:2000; FAK (06-543 from Upstate, Billerica, MA, USA) WB: 1:1000; FAK (3285 from Cell Signaling) WB (1:1000); phospho-Y397 FAK (3283 from Cell Signaling) WB: 1:1000; phospho-Y397 FAK (44624G from Biosource, Waltham, MA, USA) WB: 1:1000, IF: 1:400; ILK (611803 from Transduction Labs) WB: 1:5000; IF: 1:500; phospho-Y992 EGFR (2235 from Cell Signaling) WB: 1:2000; phospho-Y31 Paxillin (44720G from Invitrogen) WB: 1:1000; phospho-Y118 Paxillin (44722G from Invitrogen) WB: 1:1000; p130Cas (P27820 Transduction Labs) WB: 1:1000; phospho-Y410 p130 Cas (4011S from Cell Signaling) WB: 1:1000; Akt (9272 from Cell Signaling) WB: 1:1000; phospho-S473 Akt (4060 from Cell Signaling) WB: 1:1000; phosho-T308 Akt (9275 from Cell Signaling) WB: 1:1000; Erk1/2 (9102 from Cell Signaling) WB: 1:1000; Erk1/2 phosphorylated T202 Y204 (4376 Cell Signaling) WB: 1:1000.

The following secondary antibodies were used: goat anti-rabbit Alexa 488 (A11008), goat anti-mouse Alexa 488 (A11029), goat anti-rat Alexa 488 (A11006), goat anti-mouse Alexa 546 (A11003), donkey anti-mouse Alexa 647 (A31571), goat anti-rabbit Alexa 647 (A21244), (all from Invitrogen) FACS: 1:500, IF: 1:500; streptavidin-Cy5 (016170084) FACS: 1:400; goat anti-rat horseradish peroxidase (HRP) (712035150) (both from Dianova, Germany) WB: 1:10,000, donkey anti-rabbit Cy3 (711-165-152) (from Jackson ImmunoResearch, West Grove, PA, USA) IF: 1:500, goat anti-mouse HRP (172-1011) and goat anti-rabbit HRP (172-1019) (both from BioRad) WB: 1:10,000.

The FAK inhibitor PF-228 (PZ0117 from Sigma) was dissolved in dimethyl sulfoxide at 10 mM and used at 1:2000.

Expression and purification of recombinant proteins

The recombinant expression of kindlin-2, full-length paxillin (paxillin-FL) and paxillin-LIM3 in Escherichia coli Rosetta cells (Merck Millipore) was induced with 1 mM or 0.2 mM IPTG, respectively, at 18°C for 22 hr. After cell lysis and clarification of the supernatant, kindlin-2 was purified by Ni-NTA affinity chromatography (Qiagen). Eluate fractions containing kindlin-2 were pooled, cleaved with SenP2 protease and purified by size-exclusion chromatography (Superdex 200 26/600, GE Healthcare, UK) yielding unmodified murine kindlin-2. The paxillin constructs were purified by Ni-NTA affinity chromatography (Qiagen), and subsequent size-exclusion chromatography (SEC650, BioRad) to obtain N-terminally tagged His10-SUMO3-paxillin-FL and His10-SUMO3-paxillin-LIM3 domain, respectively.

Immunostaining

For immunostaining, cells were cultured on plastic ibidi-µ-slides (80826 from Ibidi, Germany) coated with 20 µg ml–1 FN (Calbiochem). Cells were routinely fixed with 4% paraformaldehyde (PFA) (w/v) in phosphate buffered saline (PBS; 180 mM NaCl, 3.5 mM KCl, 10 mM Na2HPO4, 1.8 mM K2H2PO4) for 10 min at room temperature (RT) or with –20°C cold acetone–methanol when indicated. If necessary, cells were solubilized with staining buffer (PBS supplemented with 0.1% Triton X-100 (v/v) and 3% BSA (w/v)) or with –20°C cold methanol for kindlin-2 staining. Background signals were blocked by incubating cells for 1 hr at RT in staining buffer. Subsequently, they were incubated in the dark with primary and secondary antibodies diluted in staining buffer. Fluorescent images were aquired with a LSM 780 confocal microscope (Zeiss, Germany) equiped with a 100×/NA 1.46 oil objective and with a DMIRE2-SP5 confocal microscope (Leica, Germany) equiped with a 40×/NA 1.25 or 63×/NA 1.4 oil objective using Leica Confocal software (version 2.5 build 1227). Brightfield images were aquired with an Axioskop (Carl Zeiss) 40×/NA 0.75 objective and DC500 camera with IM50 software (Leica). Z-stack projection and contrast adjustments ImageJ (v1.47) were used for further image analysis.

Super-resolution imaging was carried out by direct stochastic optical reconstruction microscopy (dSTORM), which is based on precise emitter localization. To induce reversible switching of the Alexa 647 label and reduce photobleaching, imaging was performed in imaging solution (50% Vectashield (v/v) (H-1000; Vector Laboratories, Burlingame, CA, USA), 50% TBS (v/v), pH=8.0) supplemented with 50 mM β-mercaptoethylamine (Sigma-Aldrich; M9768).

dSTORM was implemented on a custom built total internal reflection fluourescence (TIRF) system (Visitron Systems, Germany) based on a Zeiss Axiovert 200M with fiber-coupled lasers. Sample were excited with a 640 nm laser in a TIRF mode using a Zeiss α Plan-Fluar 100×/NA 1.45 oil objective. The emitted light was detected in the spectral range 660–710 nm through a Semrock FF02-685/40-25 bandpass filter (Semrock Inc., Rochester, NY, USA). Images were recorded with a Photometrics Evolve Delta emCCD camera (Photometrics, Huntington Beach, CA, USA), with its EM gain set to 250. Additional magnification by a factor of 1.6 resulted in a pixel size of 100 nm. For each final image, a total of 20,000 frames with an exposure time of 14 ms were recorded.

A standard TIRF imaging of the same sample in the green channel (anti-paxillin) was achieved by illumination with a 488 nm laser and detection in the spectral range 500–550 nm through a Chroma Et 525/50 bandpass filter (Chroma Technology Corporation, Bellows Falls, VT, USA). Simultaneous dual-colour imaging of both the green and the red channel was realized with a Hamamatsu W-View Gemini image splitter (Hamamatsu Photonics, Bridgewater, NJ, USA) mounted between the microscope and the camera. Image analysis was carried out with the ImageJ plugin ThunderSTORM and standard tools of ImageJ. Heat maps of density of blink events were created using the 2D-Frequency Count/Binning module of OriginPro 9.1 (OriginLab Corporation, Northampton, MA, USA).

AFM-based single-cell force spectroscopy

Tipless, 200 µm long V-shaped cantilevers (spring constants of 0.06 N m–1; NP-O, Bruker, Billerica, MA, USA) were prepared for cell attachment as described. Briefly, plasma cleaned cantilevers were incubated in 2 mg ml–1 ConA (Sigma) in PBS at 4°C overnight. Polydimethylsiloxan (PDMS) masks were overlaid on glass bottoms of Petri dishes (35 mm FluoroDish, World Precision Instruments, Sarasota, FL, USA) to allow different coatings of the glass surface. PDMS-framed glass surfaces were incubated overnight with 50 µg ml–1 FN-RGD and 50 µg ml–1 FN-∆RGD in PBS at 4°C. Overnight serum-starved fibroblasts (TlnCtr, KindCtr, TlnKo, KindKo) grown on FN-coated (Calbiochem) 24 well plates (Thermo Scientific, Denmark) to confluency of ~ 80% were washed with PBS and detached with 0.25% (w/v) trypsin/EDTA (Sigma). Detached cells were suspended in single-cell force spectroscopy (SCFS) medium (DMEM supplemented with 20 mM HEPES) containing 1% (v/v) FCS, pelleted and further resuspended in serum-free SCFS medium. Detached cells were left suspended in SCFS media to recover from detachment for ~1 hr. For the activation or chelation assay, the detached cells were incubated in SCFS media supplemented with 0.5 mM Mn2+ or 5 mM EDTA, respectively, for ~1 hr and SCFS was performed in the presence of the indicated supplement. SCFS was performed using an AFM (NanoWizard II, JPK Instruments, Germany) equipped with a CellHesion module (JPK Instruments) mounted on an inverted optical microscope (Zeiss Axiovert 200M). Measurements were performed at 37°C, controlled by a PetriDish Heater (JPK Instruments). Cantilevers were calibrated using the equipartition theorem.

To attach a single cell to the cantilever, cell suspensions were pipetted to the region containing the FN-∆RGD coating. The ConA functionalized cantilever was lowered onto a single cell with a velocity of 10 µm s−1 until reaching a contact force of 5 nN. After 5 s contact, the cantilever was retracted from the Petri dish by 50 µm and the cantilever-bound cell was left for incubation for >10 min. For adhesion experiments, the cantilever-bound cell was brought into contact with the FN-∆RGD coated support at a contact force of ~2 nN for 5, 20, 50 and 120 s and then retracted while measuring the cantilever deflection and the distance travelled. Subsequently, the cell adhesion to the FN-RGD coated support was characterized as described. In case cantilever attached cells showed morphological changes (e.g. spreading) they were discarded. The approach and retract velocity of the cantilever was 5 µm s–1. The deflection of the cantilever was recorded as force-distance curves. Adhesion forces were extracted from retraction force-distance curves using the AFM data processing software (JPK Instruments).

Immunoprecipitations and recombinant protein pulldown

GFP-IPs were performed using µ-MACS anti-GFP magnetic beads (130-091-288 from Miltenyi, Germany). To pulldown recombinant kindlin-2 35 µg of purified His10-LIM3 or 10 µg of purified His10-paxillin-FL were incubated with 100 µl of 50% Ni-NTA-Agarose slurry (Qiagen) in pulldown buffer (20 mM Tris, pH 7.5, 200 mM NaCl, 1 mM TCEP, 0.05% Tween20) for 1 hr at 4°C. After a first wash with 20 column volumes (CV) of pulldown buffer supplemented with 1 mM ZnCl2 and a second wash with 20 CV of pulldown buffer, 14 µg of purified kindlin-2 were added to 100 µl of Ni-NTA-agarose slurry and incubated for 30 min at 4°C. Subsequently, the Ni-NTA beads were washed three times with 20 CV of pulldown buffer supplemented with 25 mM imidazole and either 1 mM ZnCl2 or 1 mM EDTA. The beads were eluted with 50 µl pulldown buffer supplemented with 500 mM imidazole and analysed on a 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).

For immunoprecipitation of kindlin-2 or paxillin, control fibroblasts were lysed in lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Triton X-100, 0.05% sodium deoxycholate, 10 mM EDTA). Lysates were incubated with kindlin-2 or paxillin antibodies for 2 hr at 4°C while rotating. Isotype-matched IgG was used as a negative control. After this, lysates were incubated with 50 µl protein A/G Plus Agarose (Santa Cruz) for 2 hr at 4°C. Following repeated washes with lysis buffer, proteins were eluted from the beads using Laemmli buffer and analyzed by western blotting.

For the immunoprecipitation of α5 integrin from the cell surface of live cells, α5 integrins were labeled with a biotinylated anti-α5 integrin antibody (PharMingen #557446) or an isotype control (eBioscience # 13-4321) for 1 hr on ice. After two washes in ice-cold PBS to remove unbound antibody, cells were lysed in IP buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1% sodium deoxycholate, 1mM EDTA, and protease inhibitors) and cleared by centrifugation. α5 integrin immuno-complexes were pulled-down by incubation with streptavidin-sepharose (GE Healthcare) overnight at 4°C with gentle agitation. After several washes with lysis buffer, proteins were subjected to SDS-PAGE and western blot analysis with antibodies against α5 and β1 integrin.

Spreading and adhesion assays

Cells were grown to 70% confluency and then detached using trypsin/EDTA. Suspended cells were serum starved for 1 hr in adhesion assay medium (10 mM HEPES, pH 7.4; 137 mM NaCl; 1 mM MgCl2; 1 mM CaCl2; 2.7 mM KCl; 4.5 g L–1 glucose; 3% BSA (w/v)) before 40,000 cells per well were plated out in the same medium supplemented with 8% FCS, and 5 mM Mn2+ if indicated. Plastic ibidi-µ-slides (Ibidi; 80826) were coated with 10 µg ml–1 FN (Calbiochem) for adhesion or 20 µg ml–1 FN for spreading assays, 10 µg ml–1 LN (11243217001 from Roche, Germany), 10 µg ml–1 COL (5005B from Advanced Bio Matrix, Carlsbad, CA, USA), 10 µg ml–1 VN (07180 from StemCell, Canada) or 0.1% PLL (w/v) (Sigma; P4707) diluted in PBS. Seeded cells were centrifuged at 600 rpm in a Beckman centrifuge for 30 min at 37°C before they were fixed with 4% PFA (w/v) in PBS and stained with Phalloidin-TRITC and DAPI. For cell adhesion assays, nuclear staining of the whole well was imaged using a 2.5x objective and cell numbers were counted using ITCN plugin for imageJ. For cell spreading assays, 12 confocal images of different regions of Phalloidin and DAPI stained cells were aquired using a Leica confocal microscope, cell spreading was quantified using imageJ.

For time dependent and ligand concentration dependent adhesion on FN, 40,000 cells were plated on 96-well plates, vigorously washed after the indicated timepoints with PBS and fixed with 4% PFA. Cell attachment was meassured by crystal violet staining (0.1% in 20% methanol) of cells in a absorbance plate reader at the wavelength of 570 nm.

Live cell imaging

A hole of 15 mm diameter was drilled into the bottom of a 35 mm falcon tissue culture dish (353001, Becton Dickinson) and a coverslip (Ø 25 mm, Menzel-Gläser, Germany), rinsed with ethanol, was glued to the dish with silicon glue (Elastosil E43, Wacker, Germany). After coating coverslips with 20 µg ml–1 FN (Calbiochem) overnight at 4°C, cells were plated and imaged in an inverted transmission light microscope (Zeiss Axiovert 200 M, Carl Zeiss) equipped with a climate chamber. Phase contrast images were taken with a ProEM 1024 EMCCD camera (Princeton Instruments, Acton, MA, USA) through a Zeiss Plan Neofluar 100x objective (NA 1.3, Ph3). Frames were acquired at 30 sec or 1 min intervals and converted to time lapse movies using ImageJ.

Constructs and transfections

K2ΔPHGFP was cloned by PCR using the K2GFP cDNA as template and the Kind2fwd (5’-ctcgaggaggtatggctctggacgggataag -3’, Kind2PHrev 5’-tggtcttgcctttaatatagtcagcaagtt -3’), Kind2PHfwd (5’-ctatattaaaggcaagaccatggcagacag -3’) and Kind2rev (5’- tctagatcacacccaaccactggtga-3’) primers. The two fragments containing homologous regions (indicated with bold letters in the primer sequences) were fused by another round of amplification using the most 5’ and 3’ primers (Kind2fwd and Kind2rev). The resulting PCR product was cloned into the K2GFP vector. The N- and C-terminal truncation constructs of kindlin-2 were cloned by PCR using K2GFP as template. The primer sequences were: Kind2-NT-fwd 5’-ctgtacaagtccggactc-3’, Kind2-NT-rev 5’-gcggccgcctattttgctttatcaagaagagc-3’, Kind2-CT-fwd 5’-ctcgagctatggataaagcaaaaaccaaccaag-3’, Kind2-CT-rev 5’-gttatctagagcggccgc-3’. Stable expression of K2ΔPHGFP and FAKGFP- or Myc-FAK (a gift from Dr. Ambra Pozzi; Vanderbilt University, Nashville, USA) cDNAs was achieved with the sleeping beauty transposase system. Kindlin-1-GFP and Kindlin-3-GFP constructs have been described.

For stable expression of murine talin-1 and THD (amino acids1-443), the corresponding cDNAs were N-terminally tagged with Venus and cloned into the retroviral pLPCX vector. The constructs for GFP-tagged paxillin-LIM truncation mutants were generated by PCR from GFP- and Cherry-tagged α-paxillin and cloned into the retroviral pLPCX vector. The primer sequences were: stop codon in bold: ΔLIM1-4fwd 5’- caccgttgccaaatgagggtctgtggagcc -'3, ΔLIM1-4rev 5’- ggctccacagaccctcatttggcaacggtg -'3, ΔLIM2-4fwd 5’- cagcctcttctccccatgacgctgctactactg -'3, ΔLIM2-4rev 5’- cagtagtagcagcgtcatggggagaagaggctg -'3, ΔLIM3-4fwd 5’- aagattacttcgacatgtttgcttgacccaagtgcggc -'3, ΔLIM3-4rev 5’- gccgcacttgggtcaagcaaacatgtcgaagtaatctt -'3, ΔLIM4fwd 5’- ggcgcggctcgtgactgtgctccgg -'3, ΔLIM4rev 5’- ccggagcacagtcacgagccgcgcc -'3). The cDNA of murine Hic5 was amplified from a cDNA derived from murine vascular smooth muscle cells, cloned into pCR2.1-TOPO (Invitrogen) and subcloned into pEGFP-C1 vector. Murine leupaxin cDNA (cloneID: 5065405 from Thermo Scientific, Germany) was PCR-amplified (Lpxn-fwd: 5’- ctcgagcaatggaagagctggatgccttattg -3’; Lpxn-rev 5’- gaattcctactgtgaaaagagcttagtgaagc -3’) and subcloned into the pEGFP-C1 vector.

To express recombinant murine kindlin-2 and paxillin-LIM3 (A473-S533) cDNAs were fused with N-terminal tandem tags consisting of 10x-Histidine followed by a SUMO3-tag and cloned into pCoofy17. The primer sequences for amplifying the paxillin-LIM3 domain were: LIM3fwd 5’-aaccggtggagctcccaagtgc-3’ and LIM3rev 5’-ttctcgagttacgagccgcgcc-3’. The plasmid carrying FNIII7-10 cDNA has been described previously. For Y2H analysis, the kindlin-2 cDNA was PCR amplified using the primers K2-Bamfw: 5’-gggatcccactgggcctaatggctctggacgggataagg-3’ and K2-Salrev: 5’-gtgtcgacgtcacacccaaccactggtgagtttg-3’ and cloned into the pGBKT7 plasmid to obtain a kindlin-2 version that was N-terminally fused with the Gal4-DNA binding domain. Screening of this construct against a human full ORF library was conducted by the Y2H protein interaction screening service of the German Cancer Research Center in Heidelberg, Germany.

Statistical analysis

Experiments were routinely repeated at least three times and the repeat number was increased according to the effect size or sample variation. Unless stated differently, all statistical significances (*P<0.05; **P<0.01; ***P<0.001; n.s., not significant) were determined by two-tailed unpaired t-test. In the boxplots, the middle line represents the median, the box ends represent the 25th and 75th percentiles and the whisker ends show the 5th and 95th percentiles. Statistical analysis were performed with Prism (GraphPad, La Jolla, CA, USA).

References 71

  1. 1.

    Askari JA, Tynan CJ, Webb SED, Martin-Fernandez ML, Ballestrem C, Humphries MJ. Focal adhesions are sites of integrin extension. The Journal of Cell Biology. 2010;188:891-903.

    Not in our library10.1083/jcb.200907174

  2. 2.

    Azimifar SB, Bottcher RT, Zanivan S, Grashoff C, Kruger M, Legate KR, Mann M, Fassler R. Induction of membrane circular dorsal ruffles requires co-signalling of integrin-ILK-complex and EGF receptor. Journal of Cell Science. 2012;125:435-448.

    Not in our library10.1242/jcs.091652

  3. 3.

    Bachir AI, Zareno J, Moissoglu K, Plow EF, Gratton E, Horwitz AR. Integrin-associated complexes form hierarchically with variable stoichiometry in nascent adhesions. Current Biology. 2014;24:1845-1853.

    Not in our library10.1016/j.cub.2014.07.011

  4. 4.

    Bazzoni G, Shih D-T, Buck CA, Hemler ME. Monoclonal antibody 9EG7 defines a novel 1 integrin epitope induced by soluble ligand and manganese, but inhibited by calcium. Journal of Biological Chemistry. 1995;270:25570-25577.

    Not in our library10.1074/jbc.270.43.25570

  5. 5.

    Bennett JS. Structure and function of the platelet integrin IIb 3. Journal of Clinical Investigation. 2005;115:3363-3369.

    Not in our library10.1172/jci26989

  6. 6.

    Böttcher RT, Stremmel C, Meves A, Meyer H, Widmaier M, Tseng H-Y, Fässler R. Sorting nexin 17 prevents lysosomal degradation of β1 integrins by binding to the β1-integrin tail. Nature Cell Biology. 2012;14:584-592.

    Not in our library10.1038/ncb2501

  7. 7.

    Bouchard V, Demers M-J, Thibodeau S, Laquerre V, Fujita N, Tsuruo T, Beaulieu J-F, Gauthier R, Vézina A, Villeneuve L, Vachon PH. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. Journal of Cellular Physiology. 2007;212:717-728.

    Not in our library10.1002/jcp.21096

  8. 8.

    Brami-Cherrier K, Gervasi N, Arsenieva D, Walkiewicz K, Boutterin M-C, Ortega A, Leonard PG, Seantier B, Gasmi L, Bouceba T, Kadare G, Girault J-A, Arold ST. FAK dimerization controls its kinase-dependent functions at focal adhesions. The EMBO Journal. 2014;33:356-370.

    Not in our library10.1002/embj.201386399

  9. 9.

    Brown MC, Perrotta JA, Turner CE. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. The Journal of Cell Biology. 1996;135:1109-1123.

    Not in our library10.1083/jcb.135.4.1109

  10. 10.

    Byun J, Verardo MR, Sumengen B, Lewis GP, Manjunath BS, Fisher SK. Automated tool for the detection of cell nuclei in digital microscopic images: application to retinal images. Molecular Vision. 2006;12:949-960.

    Not in our library

  11. 11.

    Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nature Reviews Molecular Cell Biology. 2013;14:503-517.

    Not in our library10.1038/nrm3624

  12. 12.

    Chen W, Lou J, Zhu C. Forcing switch from short- to intermediate- and long-lived states of the a domain generates LFA-1/ICAM-1 catch bonds. Journal of Biological Chemistry. 2010;285:35967-35978.

    Not in our library10.1074/jbc.m110.155770

  13. 13.

    Choi CK, Zareno J, Digman MA, Gratton E, Horwitz AR. Cross-correlated fluctuation analysis reveals phosphorylation-regulated paxillin-FAK complexes in nascent adhesions. Biophysical Journal. 2011;100:583-592.

    Not in our library10.1016/j.bpj.2010.12.3719

  14. 14.

    Cluzel C, Saltel F, Lussi J, Paulhe F, Imhof BA, Wehrle-Haller B. The mechanisms and dynamics of v 3 integrin clustering in living cells. The Journal of Cell Biology. 2005;171:383-392.

    Not in our library10.1083/jcb.200503017

  15. 15.

    Conti FJ, Monkley SJ, Wood MR, Critchley DR, Muller U. Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions. Development. 2009;136:3597-3606.

    Not in our library10.1242/dev.035857

  16. 16.

    Coussen F, Choquet D, Sheetz MP, Erickson HP. Trimers of the fibronectin cell adhesion domain localize to actin filament bundles and undergo rearward translocation. Journal of Cell Science. 2002;115:2581-2590.

    Not in our library10.1242/jcs.115.12.2581

  17. 17.

    Deakin NO, Pignatelli J, Turner CE. Diverse roles for the paxillin family of proteins in cancer. Genes & Cancer. 2012;3:362-370.

    Not in our library10.1177/1947601912458582

  18. 18.

    Deramaudt TB, Dujardin D, Noulet F, Martin S, Vauchelles R, Takeda K, Rondé P, Parsons M. Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes. PLoS ONE. 2014;9:e10130.

    Not in our library10.1371/journal.pone.0092059

  19. 19.

    Du X, Plow EF, Frelinger AL, O'Toole TE, Loftus JC, Ginsberg MH. Ligands 'activate' integrin αIIbβ3 (platelet GPIIb-IIIa). Cell. 1991;65:409-416.

    Not in our library10.1016/0092-8674(91)90458-b

  20. 20.

    Evans R, Patzak I, Svensson L, De Filippo K, Jones K, McDowall A, Hogg N. Integrins in immunity. Journal of Cell Science. 2009;122:215-225.

    Not in our library10.1242/jcs.019117

  21. 21.

    Fassler R, Meyer M. Consequences of lack of beta 1 integrin gene expression in mice. Genes & Development. 1995;9:1896-1908.

    Not in our library10.1101/gad.9.15.1896

  22. 22.

    Friedland JC, Lee MH, Boettiger D. Mechanically activated integrin switch controls 5 1 function. Science. 2009;323:642-644.

    Not in our library10.1126/science.1168441

  23. 23.

    Friedrichs J, Helenius J, Muller DJ. Quantifying cellular adhesion to extracellular matrix components by single-cell force spectroscopy. Nature Protocols. 2010;5:1353-1361.

    Not in our library10.1038/nprot.2010.89

  24. 24.

    Fukuda K, Bledzka K, Yang J, Perera HD, Plow EF, Qin J. Molecular basis of kindlin-2 binding to integrin-linked kinase pseudokinase for regulating cell adhesion. Journal of Biological Chemistry. 2014;289:28363-28375.

    Not in our library10.1074/jbc.m114.596692

  25. 25.

    Gailit J, Ruoslahti E. Regulation of the fibronectin receptor affinity by divalent cations. The Journal of Biological Chemistry. 1988;263:12927-12932.

    Not in our library

  26. 26.

    Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Molecular and Cellular Biology. 2002;22:901-915.

    Not in our library10.1128/mcb.22.3.901-915.2002

  27. 27.

    Han J, Lim CJ, Watanabe N, Soriani A, Ratnikov B, Calderwood DA, Puzon-McLaughlin W, Lafuente EM, Boussiotis VA, Shattil SJ, Ginsberg MH. Reconstructing and deconstructing agonist-induced activation of integrin αIIbβ3. Current Biology. 2006;16:1796-1806.

    Not in our library10.1016/j.cub.2006.08.035

  28. 28.

    Harburger DS, Bouaouina M, Calderwood DA. Kindlin-1 and -2 directly bind the c-terminal region of integrin cytoplasmic tails and exert integrin-specific activation effects. Journal of Biological Chemistry. 2009;284:11485-11497.

    Not in our library10.1074/jbc.m809233200

  29. 29.

    Huet-Calderwood C, Brahme NN, Kumar N, Stiegler AL, Raghavan S, Boggon TJ, Calderwood DA. Differences in binding to the ILK complex determines kindlin isoform adhesion localization and integrin activation. Journal of Cell Science. 2014;127:4308-4321.

    Not in our library10.1242/jcs.155879

  30. 30.

    Hutter JL, Bechhoefer J. Calibration of atomic-force microscope tips. Review of Scientific Instruments. 1993;64:1868-1873.

    Not in our library10.1063/1.1143970

  31. 31.

    Hynes RO. Integrins. Cell. 2002;110:673-687.

    Not in our library10.1016/s0092-8674(02)00971-6

  32. 32.

    Kong F, Garcia AJ, Mould AP, Humphries MJ, Zhu C. Demonstration of catch bonds between an integrin and its ligand. The Journal of Cell Biology. 2009;185:1275-1284.

    Not in our library10.1083/jcb.200810002

  33. 33.

    Kong F, Li Z, Parks WM, Dumbauld DW, García AJ, Mould AP, Humphries MJ, Zhu C. Cyclic mechanical reinforcement of integrin–ligand interactions. Molecular Cell. 2013;49:1060-1068.

    Not in our library10.1016/j.molcel.2013.01.015

  34. 34.

    Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, Griffith LG. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. Journal of Cell Science. 2002;115:1423-1433.

    Not in our library10.1242/jcs.115.7.1423

  35. 35.

    Lawson C, Lim S-T, Uryu S, Chen XL, Calderwood DA, Schlaepfer DD. FAK promotes recruitment of talin to nascent adhesions to control cell motility. The Journal of Cell Biology. 2012;196:223-232.

    Not in our library10.1083/jcb.201108078

  36. 36.

    Liao Z, Kato H, Pandey M, Cantor JM, Ablooglu AJ, Ginsberg MH, Shattil SJ. Interaction of kindlin-2 with integrin 3 promotes outside-in signaling responses by the v 3 vitronectin receptor. Blood. 2015;125:1995-2004.

    Not in our library10.1182/blood-2014-09-603035

  37. 37.

    Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG. Cell adhesion and motility depend on nanoscale RGD clustering. Journal of Cell Science. 2000;113:1677-1686.

    Not in our library10.1242/jcs.113.10.1677

  38. 38.

    Margadant C, Kreft M, de Groot D-J, Norman JC, Sonnenberg A. Distinct roles of talin and kindlin in regulating integrin α5β1 function and trafficking. Current Biology. 2012;22:1554-1563.

    Not in our library10.1016/j.cub.2012.06.060

  39. 39.

    Moik D, Bottcher A, Makhina T, Grashoff C, Bulus N, Zent R, Fassler R. Mutations in the paxillin-binding site of integrin-linked kinase (iLK) destabilize the pseudokinase domain and cause embryonic lethality in mice. Journal of Biological Chemistry. 2013;288:18863-18871.

    Not in our library10.1074/jbc.m113.470476

  40. 40.

    Montanez E, Ussar S, Schifferer M, Bosl M, Zent R, Moser M, Fassler R. Kindlin-2 controls bidirectional signaling of integrins. Genes & Development. 2008;22:1325-1330.

    Not in our library10.1101/gad.469408

  41. 41.

    Moser M, Nieswandt B, Ussar S, Pozgajova M, Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nature Medicine. 2008;14:325-330.

    Not in our library10.1038/nm1722

  42. 42.

    Moser M, Legate KR, Zent R, Fassler R. The tail of integrins, talin, and kindlins. Science. 2009;324:895-899.

    Not in our library10.1126/science.1163865

  43. 43.

    Mould AP, Akiyama SK, Humphries MJ. Regulation of integrin 5 1-fibronectin interactions by divalent cations: evidence for distinct classes of binding sites for Mn2+, Mg2+, and Ca2+. Journal of Biological Chemistry. 1995;270:26270-26277.

    Not in our library10.1074/jbc.270.44.26270

  44. 44.

    Mould AP, Barton SJ, Askari JA, Craig SE, Humphries MJ. Role of ADMIDAS cation-binding site in ligand recognition by integrin 5 1. Journal of Biological Chemistry. 2003;278:51622-51629.

    Not in our library10.1074/jbc.m306655200

  45. 45.

    Nieswandt B, Moser M, Pleines I, Varga-Szabo D, Monkley S, Critchley D, Fassler R. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. Journal of Experimental Medicine. 2007;204:3113-3118.

    Not in our library10.1084/jem.20071827

  46. 46.

    Ovesny M, K i ek P, Borkovec J, vindrych Z, Hagen GM. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics. 2014;30:2389-2390.

    Not in our library10.1093/bioinformatics/btu202

  47. 47.

    Pankov R, Cukierman E, Katz BZ, Matsumoto K, Lin DC, Lin S, Hahn C, Yamada KM. Integrin dynamics and matrix assembly: tensin-dependent translocation of alpha5beta1 integrins promotes early fibronectin fibrillogenesis. The Journal of Cell Biology. 2000;148:1075-1090.

    Not in our library10.1083/jcb.148.5.1075

  48. 48.

    Roca-Cusachs P, Gauthier NC, del Rio A, Sheetz MP. Clustering of 5 1 integrins determines adhesion strength whereas v 3 and talin enable mechanotransduction. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:16245-16250.

    Not in our library10.1073/pnas.0902818106

  49. 49.

    Rognoni E, Widmaier M, Jakobson M, Ruppert R, Ussar S, Katsougkri D, Böttcher RT, Lai-Cheong JE, Rifkin DB, McGrath JA, Fässler R. Kindlin-1 controls wnt and TGF-β availability to regulate cutaneous stem cell proliferation. Nature Medicine. 2014;20:350-359.

    Not in our library10.1038/nm.3490

  50. 50.

    Scheffzek K, Welti S. Pleckstrin homology (pH) like domains – versatile modules in protein–protein interaction platforms. FEBS Letters. 2012;586:2662-2673.

    Not in our library10.1016/j.febslet.2012.06.006

  51. 51.

    Schlaepfer DD, Mitra SK, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research. 2004;1692:77-102.

    Not in our library10.1016/j.bbamcr.2004.04.008

  52. 52.

    Schubert R, Strohmeyer N, Bharadwaj M, Ramanathan SP, Krieg M, Friedrichs J, Franz CM, Muller DJ. Assay for characterizing the recovery of vertebrate cells for adhesion measurements by single-cell force spectroscopy. FEBS Letters. 2014;588:3639-3648.

    Not in our library10.1016/j.febslet.2014.06.012

  53. 53.

    Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nature Reviews Molecular Cell Biology. 2010;11:288-300.

    Not in our library10.1038/nrm2871

  54. 54.

    Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Research. 2010;38:D792-D799.

    Not in our library10.1093/nar/gkp1005

  55. 55.

    Springer TA, Dustin ML. Integrin inside-out signaling and the immunological synapse. Current Opinion in Cell Biology. 2012;24:107-115.

    Not in our library10.1016/j.ceb.2011.10.004

  56. 56.

    Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nature Reviews Cancer. 2014;14:598-610.

    Not in our library10.1038/nrc3792

  57. 57.

    Takahashi S, Leiss M, Moser M, Ohashi T, Kitao T, Heckmann D, Pfeifer A, Kessler H, Takagi J, Erickson HP, Fassler R. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly. The Journal of Cell Biology. 2007;178:167-178.

    Not in our library10.1083/jcb.200703021

  58. 58.

    te Riet J, Helenius J, Strohmeyer N, Cambi A, Figdor CG, Muller DJ. Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6. Journal of Cell Science. 2014;127:1595-1606.

    Not in our library10.1242/jcs.141077

  59. 59.

    Thwaites T, Nogueira AT, Campeotto I, Silva AP, Grieshaber SS, Carabeo RA. The chlamydia effector TarP mimics the mammalian leucine-aspartic acid motif of paxillin to subvert the focal adhesion kinase during invasion. Journal of Biological Chemistry. 2014;289:30426-30442.

    Not in our library10.1074/jbc.m114.604876

  60. 60.

    Ussar S, Wang H-V, Linder S, Fässler R, Moser M. The kindlins: subcellular localization and expression during murine development. Experimental Cell Research. 2006;312:3142-3151.

    Not in our library10.1016/j.yexcr.2006.06.030

  61. 61.
  62. 62.

    van Kooyk Y, Figdor CG. Avidity regulation of integrins: the driving force in leukocyte adhesion. Current Opinion in Cell Biology. 2000;12:542-547.

    Not in our library10.1016/s0955-0674(00)00129-0

  63. 63.

    van de Linde S, Löschberger A, Klein T, Heidbreder M, Wolter S, Heilemann M, Sauer M. Direct stochastic optical reconstruction microscopy with standard fluorescent probes. Nature Protocols. 2011;6:991-1009.

    Not in our library10.1038/nprot.2011.336

  64. 64.

    Wade R, Bohl J, Vande Pol S. Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene. 2002;21:96-107.

    Not in our library10.1038/sj.onc.1205013

  65. 65.

    Wang P, Ballestrem C, Streuli CH. The c terminus of talin links integrins to cell cycle progression. The Journal of Cell Biology. 2011;195:499-513.

    Not in our library10.1083/jcb.201104128

  66. 66.

    Winograd-Katz SE, Fässler R, Geiger B, Legate KR. The integrin adhesome: from genes and proteins to human disease. Nature Reviews Molecular Cell Biology. 2014;15:273-288.

    Not in our library10.1038/nrm3769

  67. 67.

    Xia W, Springer TA. Metal ion and ligand binding of integrin α 5 β 1. Proceedings of the National Academy of Sciences of the United States of America. 2014;111:17863-17868.

    Not in our library10.1073/pnas.1420645111

  68. 68.

    Ye F, Petrich BG, Anekal P, Lefort CT, Kasirer-Friede A, Shattil SJ, Ruppert R, Moser M, Fässler R, Ginsberg MH. The mechanism of kindlin-mediated activation of integrin αIIbβ3. Current Biology. 2013;23:2288-2295.

    Not in our library10.1016/j.cub.2013.09.050

  69. 69.

    Zhang X, Jiang G, Cai Y, Monkley SJ, Critchley DR, Sheetz MP. Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nature Cell Biology. 2008;10:1062-1068.

    Not in our library10.1038/ncb1765

  70. 70.

    Zhang X, Moore SW, Iskratsch T, Sheetz MP. N-WASP-directed actin polymerization activates cas phosphorylation and lamellipodium spreading. Journal of Cell Science. 2014;127:1394-1405.

    Not in our library10.1242/jcs.134692

  71. 71.

    Zhu J, Luo B-H, Xiao T, Zhang C, Nishida N, Springer TA. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Molecular Cell. 2008;32:849-861.

    Not in our library10.1016/j.molcel.2008.11.018

Cited by papers we hold 15

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.